Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Latigo Biotherapeutics, Inc. (LTGO) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Latigo Biotherapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2056611.
Total stock buying since 2026: $5,040,000.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 280,000 | $5,040,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-08 | 280,000 | $5,040,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-10 | Foresite Capital Fund Vi Lp | Buy | 140,000 | 18.00 | 2,520,000 |
| 2026-08-10 | Tananbaum James B. | Buy | 140,000 | 18.00 | 2,520,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of LTGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Latigo Biotherapeutics, Inc. (symbol LTGO, CIK number 2056611) see the Securities and Exchange Commission (SEC) website.